The Effect of Telerehabilitation on Functional Capacity, Oxidative Stress and Respiratory Parameters in Cystic Fibrosis
NCT ID: NCT05147285
Last Updated: 2024-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2020-10-22
2022-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Telerehabilitation on Muscle Function, Physical Activity and Sleep in Cystic Fibrosis During Pandemic
NCT04742049
Effects of a Telerehabilitation Approach in Children With Cystic Fibrosis
NCT04683809
Effects of Telerehabilitation-based Exercises in Cystic Fibrosis
NCT05590169
Comparison of the Efficacy of Comprehensive Respiratory Physiotherapy in Children With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
NCT04170114
Physical Activity, Exercise Capacity and Coronavirus Phobia of Adult Cystic Fibrosis Patients During COVID-19 Pandemic
NCT04673331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stabilization group
Only stabilization exercises in patients with cystic fibrosis
stabilization exercises
Patients will be applied only online supervised stabilization exercises three times a week for 8 weeks.
combined group
stabilization exercise and aerobic exercise training in patients with cystic fibrosis
combined exercises
Patients will be applied online supervised aerobic exercise training and stabilization exercises.Aerobic exercises will be performed for 8 weeks, for 30-45 minutes, at 65-75% of the maximum heart rate, 3 days a week, on the days when stabilization exercises are not performed.
control group
physical activity recommendations in patients with cystic fibrosis
Physical activity recommendations
The importance of physical activity will be explained to the patients and appropriate physical activity recommendations will be made.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stabilization exercises
Patients will be applied only online supervised stabilization exercises three times a week for 8 weeks.
combined exercises
Patients will be applied online supervised aerobic exercise training and stabilization exercises.Aerobic exercises will be performed for 8 weeks, for 30-45 minutes, at 65-75% of the maximum heart rate, 3 days a week, on the days when stabilization exercises are not performed.
Physical activity recommendations
The importance of physical activity will be explained to the patients and appropriate physical activity recommendations will be made.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Access to online exercise training
* Percent predicted of forced expiratory volume at one second (FEV1) \> 40% in pulmonary function test
Exclusion Criteria
* Being physically or perceptually competent to exercise
* Patients with allergic bronchopulmonary aspergillosis (ABPA) who were treated with systemic steroid therapy
* Having FEV1 %\< 40% at pulmonary function test.
8 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kübra Kılıç
Physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deniz Dogru-Ersoz, Professor
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA-20069
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.